Researchers have developed a speedy, controllable way to get two or more ingredients into the same tiny capsule and only have them mix when triggered by a signal like vibrations or heat
Chemotherapy often comes with powerful side effects, and one of the reasons for this is that the drugs used to kill cancer cells can also damage other fast-growing cells in the body, like hair follicles. But one possibility for reducing these side effects may be if the chemotherapy drugs only become toxic when they reach the tumor.
The search for such targeted drug delivery options for chemotherapy and other treatments inspired a team of researchers from the University of Science and Technology of China and The Ohio State University to develop a new way to package two or more ingredients into a single capsule. If the ingredients must be mixed for the drug to work, doctors could trigger the mixing in targeted area of the body, boosting drug efficiency while reducing side effects.
The researchers report their method for multi-ingredient encapsulation and triggered mixing in a new paper in the journal Applied Physics Letters, from AIP Publishing. While the work has shown promise because it allows the researcher to produce micro capsules, they have not yet used the technique to encapsulate cancer treatments. If such capsules can be made, they will have to prove safe and effective in clinical trials before becoming widely available to treat cancer.
“One of the limitations of chemotherapy is that less than 5 percent of the drugs typically get to the tumor, while the rest can be absorbed by other organs,” said Ronald Xu, a professor in biomedical engineering at The Ohio State University in Columbus, Ohio. One possible way to address the problem could be to make the drugs non-toxic when injected into the body and trigger mixing that would produce a toxic product only near the tumor site.
For such drugs to work on a large scale, there must be a way to quickly, controllably, and cost-effectively produce capsules with two or more active ingredients. If the drugs are to be injected and spread through the body via the bloodstream, the capsules should also be small.
Xu and his colleagues from the University of Science and Technology of China developed a device that can produce tiny capsules approximately 100 microns across (about the size of a speck of dust) with multiple inner ingredients. Ting Si, the first author on the paper and an expert in fluid mechanics, also developed mathematical models that show the relationship between process parameters, like flow rate and needle diameter, and the size of the final capsules. The models were used to achieve the designated capsule sizes.
The device works by funneling different ingredients through two inner needles. The inner needles run parallel to each other and are both enclosed in a larger outer needle, which contains an ingredient for making the outer shell of the capsule. As all the ingredients exit the needles through a single nozzle, a high-speed gas forces the liquids into a narrow stream that breaks up into individual droplets. An electric field stabilizes the flow so that uniform droplets are created. Depending on the relative flow rates, each droplet may contain two or more smaller inner droplets made from the ingredients in the inner needles.
The researchers tested their device with colored paraffin wax – red in one needle and blue in the other. The outer shell was made from sodium alginate – a material extracted from seaweed that turned gelatinous when the droplets fell into a calcium chloride solution.
Depending on the experimental conditions, the team was able to produce between 1,000 to 100,000 capsules per second, and nearly 100 percent of the inner liquids were incorporated into the capsules without any waste. Once encapsulated, the two colors of wax did not mix, because of surface tension, but the team demonstrated that they could force the red and blue wax to merge by vibrating the capsules. The team also demonstrated that they could release the inner droplets by dissolving the outer shell.
The key features of the new device are its high efficiency and yield, and the fact that the size of the droplets can be uniformly controlled, Xu said. By further fine-tuning the device’s operation Xu predicts that the team could make capsules that are 3-5 microns across, about the size of a red blood cell. The process can also be easily scaled up by building an array of nozzles and could be modified to encapsulate 3 or more active ingredients by adding additional inner needles.
While Xu and his colleagues were motivated by drug delivery, their device might also find wider use in a range of applications that require controlled reactions, such as regenerative medicine, and nuclear and chemical engineering, Xu said.
The Latest on: Targeted drug delivery
[google_news title=”” keyword=”targeted drug delivery” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Targeted drug delivery
- Scientists develop a peptide that targets lung tumors and delivers therapeutics inside cellson February 1, 2023 at 11:52 am
Lung cancer claims more lives each year than any other type of cancer worldwide. According to the World Health Organization, an estimated 1.8 million people died of lung cancer in 2020. Current ...
- What will cancer therapy look like in 2033?on February 1, 2023 at 4:53 am
Labiotech had the opportunity to put the same question to several experts: what is the future of cancer treatment?
- Drugs Hitch a Ride on Algae for Targeted Deliveryon January 31, 2023 at 11:00 pm
For more precise delivery, scientists are recruiting motile, single-celled organisms as vehicles that transport drugs to specific sites in the body. Read Interactive Article So far, researchers have ...
- Tiny Robots That Bring Targeted Drug Delivery And Treatment A Little Bit Closeron January 31, 2023 at 4:00 pm
What enables the targeted drug delivery feature is the internal pocket of fluid (dye in the experiment) and the monostable state of these origami robots. When the magnetic field is removed ...
- Many Patients Don't Receive Indicated Targeted NSCLC Therapyon January 30, 2023 at 10:36 am
About one third of Medicaid patients with metastatic non–small cell lung cancer (NSCLC) are not receiving indicated targeted therapy, a new analysis suggests. Researchers found that the rates of ...
- Stings by Harrison police, state agents lead to arrest of 2 accused heroin dealerson January 29, 2023 at 4:00 am
Two accused heroin dealers targeted in separate sting operations by Harrison police and state narcotics agents are scheduled to appear before a district judge this week to face felony drug charges.
- Colon Targeted Drug Delivery Systems Market : Key Player, Competition Weakness and Strengths from 2023 to 2028on January 26, 2023 at 3:39 pm
Final Report will add the analysis of the impact of Russia-Ukraine War and COVID-19 on this Colon Targeted Drug ...
- ClostraBio Announces Breakthrough Publication Describing Targeted Delivery of Metabolite to Gastrointestinal Tract via Oral Nanoparticles; Appoints CEOon January 24, 2023 at 8:15 am
ClostraBio co-founder, Dr. Jeffrey Hubbell said, “In today’s options for gastrointestinal issues, targeted drug delivery has become key in pharmaceutical product development. Innovative ...
- Defence's Melanoma Targeted Vaccine A1-Reprogrammed MSC (ARM) Cell Potency Validatedon January 24, 2023 at 12:15 am
Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) ("Defence" or the "Company"), a Canadian biopharmaceutical company specialized in the development of immune-oncology vaccines and drug ...
- Ural Federal University Experts Make Novel Connection With Targeted Treatment Of Bacterial Infectionson January 19, 2023 at 5:58 pm
Chemists from the Ural Federal University have proposed a new approach to targeted treatment of affected areas of the human body, in particular, bacterial infections. It is based on a nanosystem, the ...
via Bing News